nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CYP2B6—Thiotepa—urinary bladder cancer	0.233	0.33	CbGbCtD
Primidone—CYP3A4—Thiotepa—urinary bladder cancer	0.0715	0.101	CbGbCtD
Primidone—CYP2B6—Cisplatin—urinary bladder cancer	0.0642	0.0912	CbGbCtD
Primidone—CYP2C8—Fluorouracil—urinary bladder cancer	0.0573	0.0813	CbGbCtD
Primidone—CYP2C8—Etoposide—urinary bladder cancer	0.0478	0.0679	CbGbCtD
Primidone—CYP1A2—Fluorouracil—urinary bladder cancer	0.0443	0.0629	CbGbCtD
Primidone—CYP2B6—Doxorubicin—urinary bladder cancer	0.043	0.0611	CbGbCtD
Primidone—CYP2C9—Fluorouracil—urinary bladder cancer	0.0399	0.0567	CbGbCtD
Primidone—CYP1A2—Etoposide—urinary bladder cancer	0.037	0.0525	CbGbCtD
Primidone—CYP2C9—Cisplatin—urinary bladder cancer	0.0339	0.0482	CbGbCtD
Primidone—CYP3A4—Etoposide—urinary bladder cancer	0.0194	0.0275	CbGbCtD
Primidone—CYP3A4—Doxorubicin—urinary bladder cancer	0.0132	0.0188	CbGbCtD
Primidone—Phenobarbital—CYP4B1—urinary bladder cancer	0.0106	1	CrCbGaD
Primidone—Anaemia megaloblastic—Methotrexate—urinary bladder cancer	0.00534	0.0296	CcSEcCtD
Primidone—Eruption—Gemcitabine—urinary bladder cancer	0.004	0.0222	CcSEcCtD
Primidone—Anaemia—Valrubicin—urinary bladder cancer	0.00341	0.0189	CcSEcCtD
Primidone—Nystagmus—Fluorouracil—urinary bladder cancer	0.00339	0.0188	CcSEcCtD
Primidone—Drowsiness—Mitomycin—urinary bladder cancer	0.00325	0.018	CcSEcCtD
Primidone—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.00274	0.0152	CcSEcCtD
Primidone—Anaemia—Mitomycin—urinary bladder cancer	0.00235	0.013	CcSEcCtD
Primidone—Asthenia—Valrubicin—urinary bladder cancer	0.00216	0.012	CcSEcCtD
Primidone—Eruption—Methotrexate—urinary bladder cancer	0.00205	0.0113	CcSEcCtD
Primidone—Ataxia—Thiotepa—urinary bladder cancer	0.002	0.0111	CcSEcCtD
Primidone—Dizziness—Valrubicin—urinary bladder cancer	0.00199	0.011	CcSEcCtD
Primidone—Anorexia—Mitomycin—urinary bladder cancer	0.00198	0.011	CcSEcCtD
Primidone—Vomiting—Valrubicin—urinary bladder cancer	0.00191	0.0106	CcSEcCtD
Primidone—Eruption—Epirubicin—urinary bladder cancer	0.00191	0.0106	CcSEcCtD
Primidone—Rash—Valrubicin—urinary bladder cancer	0.0019	0.0105	CcSEcCtD
Primidone—Dermatitis—Valrubicin—urinary bladder cancer	0.0019	0.0105	CcSEcCtD
Primidone—Headache—Valrubicin—urinary bladder cancer	0.00189	0.0105	CcSEcCtD
Primidone—Somnolence—Mitomycin—urinary bladder cancer	0.00184	0.0102	CcSEcCtD
Primidone—Decreased appetite—Mitomycin—urinary bladder cancer	0.0018	0.00999	CcSEcCtD
Primidone—Nausea—Valrubicin—urinary bladder cancer	0.00179	0.00991	CcSEcCtD
Primidone—Fatigue—Mitomycin—urinary bladder cancer	0.00179	0.00991	CcSEcCtD
Primidone—Eruption—Doxorubicin—urinary bladder cancer	0.00177	0.00981	CcSEcCtD
Primidone—Ataxia—Fluorouracil—urinary bladder cancer	0.00165	0.00915	CcSEcCtD
Primidone—Nystagmus—Epirubicin—urinary bladder cancer	0.00165	0.00913	CcSEcCtD
Primidone—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00153	0.00846	CcSEcCtD
Primidone—Nystagmus—Doxorubicin—urinary bladder cancer	0.00153	0.00845	CcSEcCtD
Primidone—Asthenia—Mitomycin—urinary bladder cancer	0.00149	0.00825	CcSEcCtD
Primidone—Connective tissue disorder—Thiotepa—urinary bladder cancer	0.00144	0.008	CcSEcCtD
Primidone—Blood disorder—Epirubicin—urinary bladder cancer	0.00141	0.00781	CcSEcCtD
Primidone—Eye disorder—Thiotepa—urinary bladder cancer	0.00137	0.0076	CcSEcCtD
Primidone—Dizziness—Mitomycin—urinary bladder cancer	0.00137	0.0076	CcSEcCtD
Primidone—Vomiting—Mitomycin—urinary bladder cancer	0.00132	0.00731	CcSEcCtD
Primidone—Rash—Mitomycin—urinary bladder cancer	0.00131	0.00725	CcSEcCtD
Primidone—Dermatitis—Mitomycin—urinary bladder cancer	0.00131	0.00724	CcSEcCtD
Primidone—Blood disorder—Doxorubicin—urinary bladder cancer	0.0013	0.00723	CcSEcCtD
Primidone—Headache—Mitomycin—urinary bladder cancer	0.0013	0.0072	CcSEcCtD
Primidone—Mental disorder—Thiotepa—urinary bladder cancer	0.00129	0.00713	CcSEcCtD
Primidone—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00128	0.00712	CcSEcCtD
Primidone—Malnutrition—Thiotepa—urinary bladder cancer	0.00128	0.00708	CcSEcCtD
Primidone—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00126	0.007	CcSEcCtD
Primidone—Nausea—Mitomycin—urinary bladder cancer	0.00123	0.00683	CcSEcCtD
Primidone—Connective tissue disorder—Gemcitabine—urinary bladder cancer	0.00121	0.00673	CcSEcCtD
Primidone—Anaemia—Thiotepa—urinary bladder cancer	0.00118	0.00655	CcSEcCtD
Primidone—Connective tissue disorder—Cisplatin—urinary bladder cancer	0.00113	0.00627	CcSEcCtD
Primidone—Visual impairment—Cisplatin—urinary bladder cancer	0.00111	0.00615	CcSEcCtD
Primidone—Agranulocytosis—Etoposide—urinary bladder cancer	0.0011	0.00608	CcSEcCtD
Primidone—Arthralgia—Thiotepa—urinary bladder cancer	0.00109	0.00603	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.00108	0.00599	CcSEcCtD
Primidone—Eye disorder—Cisplatin—urinary bladder cancer	0.00108	0.00596	CcSEcCtD
Primidone—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00102	0.00567	CcSEcCtD
Primidone—Skin disorder—Thiotepa—urinary bladder cancer	0.00101	0.00562	CcSEcCtD
Primidone—Malnutrition—Cisplatin—urinary bladder cancer	0.001	0.00555	CcSEcCtD
Primidone—Anorexia—Thiotepa—urinary bladder cancer	0.000994	0.00551	CcSEcCtD
Primidone—Anaemia—Gemcitabine—urinary bladder cancer	0.000994	0.00551	CcSEcCtD
Primidone—Eye disorder—Etoposide—urinary bladder cancer	0.000986	0.00546	CcSEcCtD
Primidone—Anaemia—Fluorouracil—urinary bladder cancer	0.000977	0.00541	CcSEcCtD
Primidone—Visual disturbance—Methotrexate—urinary bladder cancer	0.000964	0.00534	CcSEcCtD
Primidone—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00095	0.00527	CcSEcCtD
Primidone—Somnolence—Thiotepa—urinary bladder cancer	0.000927	0.00514	CcSEcCtD
Primidone—Anaemia—Cisplatin—urinary bladder cancer	0.000926	0.00513	CcSEcCtD
Primidone—Arthralgia—Gemcitabine—urinary bladder cancer	0.000915	0.00507	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000909	0.00504	CcSEcCtD
Primidone—Decreased appetite—Thiotepa—urinary bladder cancer	0.000907	0.00503	CcSEcCtD
Primidone—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000901	0.00499	CcSEcCtD
Primidone—Fatigue—Thiotepa—urinary bladder cancer	0.000899	0.00498	CcSEcCtD
Primidone—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000861	0.00477	CcSEcCtD
Primidone—Ataxia—Methotrexate—urinary bladder cancer	0.000859	0.00476	CcSEcCtD
Primidone—Diplopia—Epirubicin—urinary bladder cancer	0.000855	0.00474	CcSEcCtD
Primidone—Skin disorder—Gemcitabine—urinary bladder cancer	0.000852	0.00472	CcSEcCtD
Primidone—Anaemia—Etoposide—urinary bladder cancer	0.000849	0.0047	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000847	0.0047	CcSEcCtD
Primidone—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000846	0.00469	CcSEcCtD
Primidone—Anorexia—Gemcitabine—urinary bladder cancer	0.000836	0.00464	CcSEcCtD
Primidone—Vertigo—Etoposide—urinary bladder cancer	0.000825	0.00457	CcSEcCtD
Primidone—Anorexia—Fluorouracil—urinary bladder cancer	0.000822	0.00456	CcSEcCtD
Primidone—Ataxia—Epirubicin—urinary bladder cancer	0.000804	0.00445	CcSEcCtD
Primidone—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000802	0.00445	CcSEcCtD
Primidone—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.0008	0.00443	CcSEcCtD
Primidone—Skin disorder—Cisplatin—urinary bladder cancer	0.000794	0.0044	CcSEcCtD
Primidone—Diplopia—Doxorubicin—urinary bladder cancer	0.000791	0.00438	CcSEcCtD
Primidone—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000786	0.00436	CcSEcCtD
Primidone—Somnolence—Gemcitabine—urinary bladder cancer	0.00078	0.00432	CcSEcCtD
Primidone—Anorexia—Cisplatin—urinary bladder cancer	0.00078	0.00432	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000776	0.0043	CcSEcCtD
Primidone—Somnolence—Fluorouracil—urinary bladder cancer	0.000767	0.00425	CcSEcCtD
Primidone—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000763	0.00423	CcSEcCtD
Primidone—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000758	0.0042	CcSEcCtD
Primidone—Fatigue—Gemcitabine—urinary bladder cancer	0.000757	0.00419	CcSEcCtD
Primidone—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00075	0.00416	CcSEcCtD
Primidone—Asthenia—Thiotepa—urinary bladder cancer	0.000748	0.00415	CcSEcCtD
Primidone—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000745	0.00413	CcSEcCtD
Primidone—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000745	0.00413	CcSEcCtD
Primidone—Ataxia—Doxorubicin—urinary bladder cancer	0.000744	0.00412	CcSEcCtD
Primidone—Skin disorder—Etoposide—urinary bladder cancer	0.000728	0.00403	CcSEcCtD
Primidone—Anorexia—Etoposide—urinary bladder cancer	0.000714	0.00396	CcSEcCtD
Primidone—Decreased appetite—Cisplatin—urinary bladder cancer	0.000711	0.00394	CcSEcCtD
Primidone—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000706	0.00391	CcSEcCtD
Primidone—Drowsiness—Methotrexate—urinary bladder cancer	0.000704	0.0039	CcSEcCtD
Primidone—Depression—Methotrexate—urinary bladder cancer	0.000702	0.00389	CcSEcCtD
Primidone—Dizziness—Thiotepa—urinary bladder cancer	0.00069	0.00382	CcSEcCtD
Primidone—Somnolence—Etoposide—urinary bladder cancer	0.000666	0.00369	CcSEcCtD
Primidone—Vomiting—Thiotepa—urinary bladder cancer	0.000663	0.00368	CcSEcCtD
Primidone—Drowsiness—Epirubicin—urinary bladder cancer	0.000659	0.00365	CcSEcCtD
Primidone—Rash—Thiotepa—urinary bladder cancer	0.000658	0.00365	CcSEcCtD
Primidone—Dermatitis—Thiotepa—urinary bladder cancer	0.000657	0.00364	CcSEcCtD
Primidone—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000657	0.00364	CcSEcCtD
Primidone—Headache—Thiotepa—urinary bladder cancer	0.000654	0.00362	CcSEcCtD
Primidone—Decreased appetite—Etoposide—urinary bladder cancer	0.000651	0.00361	CcSEcCtD
Primidone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000647	0.00359	CcSEcCtD
Primidone—Fatigue—Etoposide—urinary bladder cancer	0.000646	0.00358	CcSEcCtD
Primidone—Asthenia—Gemcitabine—urinary bladder cancer	0.00063	0.00349	CcSEcCtD
Primidone—Nausea—Thiotepa—urinary bladder cancer	0.00062	0.00343	CcSEcCtD
Primidone—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000615	0.00341	CcSEcCtD
Primidone—Drowsiness—Doxorubicin—urinary bladder cancer	0.000609	0.00338	CcSEcCtD
Primidone—Visual impairment—Methotrexate—urinary bladder cancer	0.000609	0.00337	CcSEcCtD
Primidone—Eye disorder—Methotrexate—urinary bladder cancer	0.00059	0.00327	CcSEcCtD
Primidone—Asthenia—Cisplatin—urinary bladder cancer	0.000587	0.00325	CcSEcCtD
Primidone—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000581	0.00322	CcSEcCtD
Primidone—Dizziness—Fluorouracil—urinary bladder cancer	0.000571	0.00316	CcSEcCtD
Primidone—Visual impairment—Epirubicin—urinary bladder cancer	0.00057	0.00316	CcSEcCtD
Primidone—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000569	0.00315	CcSEcCtD
Primidone—Vomiting—Gemcitabine—urinary bladder cancer	0.000558	0.00309	CcSEcCtD
Primidone—Mental disorder—Methotrexate—urinary bladder cancer	0.000553	0.00307	CcSEcCtD
Primidone—Rash—Gemcitabine—urinary bladder cancer	0.000553	0.00307	CcSEcCtD
Primidone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000553	0.00306	CcSEcCtD
Primidone—Eye disorder—Epirubicin—urinary bladder cancer	0.000553	0.00306	CcSEcCtD
Primidone—Malnutrition—Methotrexate—urinary bladder cancer	0.00055	0.00305	CcSEcCtD
Primidone—Headache—Gemcitabine—urinary bladder cancer	0.00055	0.00305	CcSEcCtD
Primidone—Vomiting—Fluorouracil—urinary bladder cancer	0.000549	0.00304	CcSEcCtD
Primidone—Rash—Fluorouracil—urinary bladder cancer	0.000544	0.00301	CcSEcCtD
Primidone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000544	0.00301	CcSEcCtD
Primidone—Headache—Fluorouracil—urinary bladder cancer	0.000541	0.003	CcSEcCtD
Primidone—Asthenia—Etoposide—urinary bladder cancer	0.000538	0.00298	CcSEcCtD
Primidone—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000538	0.00298	CcSEcCtD
Primidone—Visual impairment—Doxorubicin—urinary bladder cancer	0.000527	0.00292	CcSEcCtD
Primidone—Nausea—Gemcitabine—urinary bladder cancer	0.000521	0.00289	CcSEcCtD
Primidone—Vomiting—Cisplatin—urinary bladder cancer	0.00052	0.00288	CcSEcCtD
Primidone—Mental disorder—Epirubicin—urinary bladder cancer	0.000518	0.00287	CcSEcCtD
Primidone—Rash—Cisplatin—urinary bladder cancer	0.000516	0.00286	CcSEcCtD
Primidone—Dermatitis—Cisplatin—urinary bladder cancer	0.000515	0.00286	CcSEcCtD
Primidone—Malnutrition—Epirubicin—urinary bladder cancer	0.000515	0.00285	CcSEcCtD
Primidone—Nausea—Fluorouracil—urinary bladder cancer	0.000512	0.00284	CcSEcCtD
Primidone—Eye disorder—Doxorubicin—urinary bladder cancer	0.000511	0.00283	CcSEcCtD
Primidone—Anaemia—Methotrexate—urinary bladder cancer	0.000508	0.00282	CcSEcCtD
Primidone—Dizziness—Etoposide—urinary bladder cancer	0.000496	0.00275	CcSEcCtD
Primidone—Vertigo—Methotrexate—urinary bladder cancer	0.000494	0.00274	CcSEcCtD
Primidone—Nausea—Cisplatin—urinary bladder cancer	0.000486	0.00269	CcSEcCtD
Primidone—Mental disorder—Doxorubicin—urinary bladder cancer	0.000479	0.00266	CcSEcCtD
Primidone—Vomiting—Etoposide—urinary bladder cancer	0.000476	0.00264	CcSEcCtD
Primidone—Malnutrition—Doxorubicin—urinary bladder cancer	0.000476	0.00264	CcSEcCtD
Primidone—Anaemia—Epirubicin—urinary bladder cancer	0.000476	0.00264	CcSEcCtD
Primidone—Rash—Etoposide—urinary bladder cancer	0.000472	0.00262	CcSEcCtD
Primidone—Dermatitis—Etoposide—urinary bladder cancer	0.000472	0.00262	CcSEcCtD
Primidone—Headache—Etoposide—urinary bladder cancer	0.000469	0.0026	CcSEcCtD
Primidone—Arthralgia—Methotrexate—urinary bladder cancer	0.000468	0.00259	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000465	0.00258	CcSEcCtD
Primidone—Vertigo—Epirubicin—urinary bladder cancer	0.000462	0.00256	CcSEcCtD
Primidone—Nausea—Etoposide—urinary bladder cancer	0.000445	0.00247	CcSEcCtD
Primidone—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00044	0.00244	CcSEcCtD
Primidone—Anaemia—Doxorubicin—urinary bladder cancer	0.00044	0.00244	CcSEcCtD
Primidone—Arthralgia—Epirubicin—urinary bladder cancer	0.000438	0.00243	CcSEcCtD
Primidone—Skin disorder—Methotrexate—urinary bladder cancer	0.000436	0.00242	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000435	0.00241	CcSEcCtD
Primidone—Vertigo—Doxorubicin—urinary bladder cancer	0.000428	0.00237	CcSEcCtD
Primidone—Anorexia—Methotrexate—urinary bladder cancer	0.000428	0.00237	CcSEcCtD
Primidone—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000412	0.00228	CcSEcCtD
Primidone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000409	0.00227	CcSEcCtD
Primidone—Skin disorder—Epirubicin—urinary bladder cancer	0.000408	0.00226	CcSEcCtD
Primidone—Arthralgia—Doxorubicin—urinary bladder cancer	0.000405	0.00225	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000403	0.00223	CcSEcCtD
Primidone—Anorexia—Epirubicin—urinary bladder cancer	0.0004	0.00222	CcSEcCtD
Primidone—Somnolence—Methotrexate—urinary bladder cancer	0.000399	0.00221	CcSEcCtD
Primidone—Decreased appetite—Methotrexate—urinary bladder cancer	0.00039	0.00216	CcSEcCtD
Primidone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000387	0.00215	CcSEcCtD
Primidone—Fatigue—Methotrexate—urinary bladder cancer	0.000387	0.00214	CcSEcCtD
Primidone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000383	0.00212	CcSEcCtD
Primidone—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000381	0.00211	CcSEcCtD
Primidone—Skin disorder—Doxorubicin—urinary bladder cancer	0.000378	0.00209	CcSEcCtD
Primidone—Somnolence—Epirubicin—urinary bladder cancer	0.000373	0.00207	CcSEcCtD
Primidone—Anorexia—Doxorubicin—urinary bladder cancer	0.00037	0.00205	CcSEcCtD
Primidone—Decreased appetite—Epirubicin—urinary bladder cancer	0.000365	0.00202	CcSEcCtD
Primidone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000363	0.00201	CcSEcCtD
Primidone—Fatigue—Epirubicin—urinary bladder cancer	0.000362	0.00201	CcSEcCtD
Primidone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000354	0.00196	CcSEcCtD
Primidone—Somnolence—Doxorubicin—urinary bladder cancer	0.000346	0.00191	CcSEcCtD
Primidone—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000338	0.00187	CcSEcCtD
Primidone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000336	0.00186	CcSEcCtD
Primidone—Fatigue—Doxorubicin—urinary bladder cancer	0.000335	0.00186	CcSEcCtD
Primidone—Asthenia—Methotrexate—urinary bladder cancer	0.000322	0.00178	CcSEcCtD
Primidone—Asthenia—Epirubicin—urinary bladder cancer	0.000301	0.00167	CcSEcCtD
Primidone—Dizziness—Methotrexate—urinary bladder cancer	0.000297	0.00164	CcSEcCtD
Primidone—Vomiting—Methotrexate—urinary bladder cancer	0.000285	0.00158	CcSEcCtD
Primidone—Rash—Methotrexate—urinary bladder cancer	0.000283	0.00157	CcSEcCtD
Primidone—Dermatitis—Methotrexate—urinary bladder cancer	0.000283	0.00157	CcSEcCtD
Primidone—Headache—Methotrexate—urinary bladder cancer	0.000281	0.00156	CcSEcCtD
Primidone—Asthenia—Doxorubicin—urinary bladder cancer	0.000279	0.00155	CcSEcCtD
Primidone—Dizziness—Epirubicin—urinary bladder cancer	0.000278	0.00154	CcSEcCtD
Primidone—Vomiting—Epirubicin—urinary bladder cancer	0.000267	0.00148	CcSEcCtD
Primidone—Nausea—Methotrexate—urinary bladder cancer	0.000267	0.00148	CcSEcCtD
Primidone—Rash—Epirubicin—urinary bladder cancer	0.000265	0.00147	CcSEcCtD
Primidone—Dermatitis—Epirubicin—urinary bladder cancer	0.000265	0.00147	CcSEcCtD
Primidone—Headache—Epirubicin—urinary bladder cancer	0.000263	0.00146	CcSEcCtD
Primidone—Dizziness—Doxorubicin—urinary bladder cancer	0.000257	0.00142	CcSEcCtD
Primidone—Nausea—Epirubicin—urinary bladder cancer	0.000249	0.00138	CcSEcCtD
Primidone—Vomiting—Doxorubicin—urinary bladder cancer	0.000247	0.00137	CcSEcCtD
Primidone—Rash—Doxorubicin—urinary bladder cancer	0.000245	0.00136	CcSEcCtD
Primidone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000245	0.00136	CcSEcCtD
Primidone—Headache—Doxorubicin—urinary bladder cancer	0.000243	0.00135	CcSEcCtD
Primidone—Nausea—Doxorubicin—urinary bladder cancer	0.000231	0.00128	CcSEcCtD
Primidone—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	9.03e-05	0.000862	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	8.96e-05	0.000856	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	8.91e-05	0.000851	CbGpPWpGaD
Primidone—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.91e-05	0.000851	CbGpPWpGaD
Primidone—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.84e-05	0.000844	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	8.79e-05	0.000839	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	8.53e-05	0.000814	CbGpPWpGaD
Primidone—GRIK2—Neuronal System—HRAS—urinary bladder cancer	8.34e-05	0.000796	CbGpPWpGaD
Primidone—GRIA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	8.33e-05	0.000795	CbGpPWpGaD
Primidone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	8.32e-05	0.000794	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	8.26e-05	0.000789	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	8.24e-05	0.000786	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.23e-05	0.000785	CbGpPWpGaD
Primidone—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.12e-05	0.000776	CbGpPWpGaD
Primidone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	8.08e-05	0.000772	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	8.08e-05	0.000771	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	8.08e-05	0.000771	CbGpPWpGaD
Primidone—CHRNA4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	8.08e-05	0.000771	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	7.97e-05	0.000761	CbGpPWpGaD
Primidone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7.94e-05	0.000758	CbGpPWpGaD
Primidone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7.8e-05	0.000745	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	7.69e-05	0.000735	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	7.69e-05	0.000735	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	7.66e-05	0.000731	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	7.63e-05	0.000729	CbGpPWpGaD
Primidone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7.61e-05	0.000726	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—HRAS—urinary bladder cancer	7.59e-05	0.000725	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	7.55e-05	0.000721	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—NAT1—urinary bladder cancer	7.55e-05	0.000721	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.55e-05	0.000721	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	7.23e-05	0.000691	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	7.04e-05	0.000672	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.94e-05	0.000663	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.93e-05	0.000661	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	6.91e-05	0.00066	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.84e-05	0.000653	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	6.75e-05	0.000644	CbGpPWpGaD
Primidone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.65e-05	0.000635	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	6.49e-05	0.000619	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—NAT1—urinary bladder cancer	6.4e-05	0.000611	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	6.4e-05	0.000611	CbGpPWpGaD
Primidone—GRIA2—Neuronal System—HRAS—urinary bladder cancer	6.38e-05	0.000609	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.29e-05	0.000601	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.25e-05	0.000597	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	6.22e-05	0.000594	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—HRAS—urinary bladder cancer	6.19e-05	0.000591	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.12e-05	0.000584	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.08e-05	0.00058	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.04e-05	0.000577	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	6.02e-05	0.000575	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.97e-05	0.00057	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.91e-05	0.000564	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	5.88e-05	0.000561	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.86e-05	0.00056	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	5.85e-05	0.000558	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.83e-05	0.000557	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	5.73e-05	0.000547	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.72e-05	0.000546	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	5.71e-05	0.000545	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—NAT1—urinary bladder cancer	5.71e-05	0.000545	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.62e-05	0.000536	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.53e-05	0.000528	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	5.49e-05	0.000524	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.43e-05	0.000519	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.37e-05	0.000513	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.36e-05	0.000511	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—HRAS—urinary bladder cancer	5.31e-05	0.000507	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.27e-05	0.000503	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	5.27e-05	0.000503	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—HRAS—urinary bladder cancer	5.24e-05	0.0005	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	5.22e-05	0.000498	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	5.21e-05	0.000497	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—NAT1—urinary bladder cancer	5.21e-05	0.000497	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.18e-05	0.000495	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.12e-05	0.000489	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.06e-05	0.000483	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5e-05	0.000477	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	4.97e-05	0.000475	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	4.85e-05	0.000463	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—HRAS—urinary bladder cancer	4.79e-05	0.000457	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	4.76e-05	0.000454	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	4.7e-05	0.000449	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	4.69e-05	0.000448	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—HRAS—urinary bladder cancer	4.66e-05	0.000444	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—TYMP—urinary bladder cancer	4.58e-05	0.000437	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—HRAS—urinary bladder cancer	4.57e-05	0.000436	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—HRAS—urinary bladder cancer	4.49e-05	0.000429	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	4.45e-05	0.000425	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—NAT1—urinary bladder cancer	4.45e-05	0.000425	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	4.44e-05	0.000424	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.42e-05	0.000422	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—HRAS—urinary bladder cancer	4.38e-05	0.000418	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.38e-05	0.000418	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	4.33e-05	0.000413	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	4.29e-05	0.000409	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—NAT2—urinary bladder cancer	4.14e-05	0.000395	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	4.07e-05	0.000388	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	4.05e-05	0.000386	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.95e-05	0.000377	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.89e-05	0.000371	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—TYMP—urinary bladder cancer	3.88e-05	0.00037	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—HRAS—urinary bladder cancer	3.83e-05	0.000366	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.72e-05	0.000355	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.66e-05	0.00035	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.62e-05	0.000346	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—RRM2—urinary bladder cancer	3.57e-05	0.000341	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—NAT2—urinary bladder cancer	3.5e-05	0.000335	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.47e-05	0.000331	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.46e-05	0.00033	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.46e-05	0.00033	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.43e-05	0.000328	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.43e-05	0.000328	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.37e-05	0.000322	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.32e-05	0.000317	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	3.31e-05	0.000316	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ENO2—urinary bladder cancer	3.31e-05	0.000316	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	3.21e-05	0.000306	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.16e-05	0.000302	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—TYMP—urinary bladder cancer	3.15e-05	0.000301	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.14e-05	0.0003	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—NAT2—urinary bladder cancer	3.13e-05	0.000299	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.03e-05	0.000289	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—RRM2—urinary bladder cancer	3.03e-05	0.000289	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.85e-05	0.000272	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.83e-05	0.00027	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ENO2—urinary bladder cancer	2.8e-05	0.000267	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	2.8e-05	0.000267	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.79e-05	0.000266	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	2.72e-05	0.000259	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.7e-05	0.000258	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.7e-05	0.000258	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.7e-05	0.000257	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.68e-05	0.000255	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.67e-05	0.000255	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.67e-05	0.000255	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.6e-05	0.000248	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.59e-05	0.000247	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.5e-05	0.000239	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.5e-05	0.000239	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.49e-05	0.000237	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.46e-05	0.000235	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.44e-05	0.000233	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.43e-05	0.000232	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.39e-05	0.000228	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.28e-05	0.000218	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.28e-05	0.000218	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.27e-05	0.000216	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—NQO1—urinary bladder cancer	2.26e-05	0.000216	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	2.22e-05	0.000212	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.21e-05	0.000211	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.19e-05	0.000209	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.18e-05	0.000208	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.1e-05	0.000201	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.08e-05	0.000199	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—TYMS—urinary bladder cancer	2.07e-05	0.000197	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	2.04e-05	0.000195	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	2.04e-05	0.000195	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.02e-05	0.000192	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.96e-05	0.000187	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.96e-05	0.000187	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.95e-05	0.000186	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.95e-05	0.000186	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.94e-05	0.000185	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.92e-05	0.000183	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.91e-05	0.000182	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.89e-05	0.00018	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.88e-05	0.00018	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.88e-05	0.00018	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.86e-05	0.000178	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.84e-05	0.000175	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.82e-05	0.000174	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.81e-05	0.000172	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.78e-05	0.00017	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.75e-05	0.000167	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.73e-05	0.000165	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.73e-05	0.000165	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.71e-05	0.000163	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.68e-05	0.00016	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.66e-05	0.000158	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.63e-05	0.000155	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.63e-05	0.000155	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.62e-05	0.000155	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.57e-05	0.00015	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.56e-05	0.000149	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.56e-05	0.000148	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.54e-05	0.000147	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.54e-05	0.000147	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.53e-05	0.000146	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.53e-05	0.000146	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.52e-05	0.000145	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.5e-05	0.000144	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.5e-05	0.000144	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.48e-05	0.000142	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.48e-05	0.000141	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.47e-05	0.00014	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.46e-05	0.000139	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.45e-05	0.000139	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.43e-05	0.000136	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.41e-05	0.000134	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.41e-05	0.000134	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.41e-05	0.000134	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.37e-05	0.00013	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.35e-05	0.000129	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.33e-05	0.000127	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.32e-05	0.000126	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.31e-05	0.000125	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.27e-05	0.000121	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.24e-05	0.000119	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.24e-05	0.000118	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.22e-05	0.000116	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.21e-05	0.000116	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.2e-05	0.000115	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.2e-05	0.000115	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.19e-05	0.000114	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.15e-05	0.00011	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.15e-05	0.00011	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.13e-05	0.000108	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.11e-05	0.000106	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.06e-05	0.000102	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.06e-05	0.000102	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.01e-05	9.65e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.01e-05	9.64e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.01e-05	9.6e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	9.76e-06	9.31e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	9.7e-06	9.26e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—EP300—urinary bladder cancer	9.59e-06	9.15e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	9.4e-06	8.97e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	9.29e-06	8.87e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	9.29e-06	8.87e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	8.9e-06	8.49e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8.73e-06	8.34e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	8.71e-06	8.31e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PPARG—urinary bladder cancer	8.63e-06	8.24e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PTEN—urinary bladder cancer	8.51e-06	8.12e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	8.29e-06	7.91e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.21e-06	7.84e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—EP300—urinary bladder cancer	8.12e-06	7.75e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	7.94e-06	7.58e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PTEN—urinary bladder cancer	7.6e-06	7.25e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—EP300—urinary bladder cancer	7.24e-06	6.91e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PTEN—urinary bladder cancer	6.93e-06	6.61e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	6.79e-06	6.48e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.66e-06	6.36e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—EP300—urinary bladder cancer	6.61e-06	6.31e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.4e-06	6.11e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PTEN—urinary bladder cancer	5.92e-06	5.65e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—EP300—urinary bladder cancer	5.64e-06	5.39e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.24e-06	5e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.57e-06	4.36e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.36e-06	4.16e-05	CbGpPWpGaD
